83 related articles for article (PubMed ID: 1530955)
1. Abnormal immune adherence and elimination of hepatitis B surface antigen/antibody complexes in patients with AIDS.
Madi N; Steiger G; Estreicher J; Schifferli JA
J Immunol; 1992 Feb; 148(3):723-8. PubMed ID: 1530955
[TBL] [Abstract][Full Text] [Related]
2. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
Schifferli JA; Ng YC; Paccaud JP; Walport MJ
Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
[TBL] [Abstract][Full Text] [Related]
3. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.
Schifferli JA; Ng YC; Estreicher J; Walport MJ
J Immunol; 1988 Feb; 140(3):899-904. PubMed ID: 2963069
[TBL] [Abstract][Full Text] [Related]
4. Immune adherence of nascent hepatitis B surface antigen-antibody complexes in vivo in humans.
Madi N; Paccaud JP; Steiger G; Schifferli JA
Clin Exp Immunol; 1989 Nov; 78(2):201-6. PubMed ID: 12412749
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection.
Jouvin MH; Rozenbaum W; Russo R; Kazatchkine MD
AIDS; 1987 Jul; 1(2):89-94. PubMed ID: 2966632
[TBL] [Abstract][Full Text] [Related]
6. Splenic uptake of immune complexes in man is complement-dependent.
Davies KA; Erlendsson K; Beynon HL; Peters AM; Steinsson K; Valdimarsson H; Walport MJ
J Immunol; 1993 Oct; 151(7):3866-73. PubMed ID: 8376807
[TBL] [Abstract][Full Text] [Related]
7. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
Paccaud JP; Carpentier JL; Schifferli JA
Eur J Immunol; 1990 Feb; 20(2):283-9. PubMed ID: 2138082
[TBL] [Abstract][Full Text] [Related]
8. A study of in vivo immune complex formation and clearance in man.
Davies KA; Hird V; Stewart S; Sivolapenko GB; Jose P; Epenetos AA; Walport MJ
J Immunol; 1990 Jun; 144(12):4613-20. PubMed ID: 2141040
[TBL] [Abstract][Full Text] [Related]
9. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
Emlen W; Burdick G; Carl V; Lachmann PJ
J Immunol; 1989 Jun; 142(12):4366-71. PubMed ID: 2524529
[TBL] [Abstract][Full Text] [Related]
10. Defective immune adherence and elimination of hepatitis B surface antigen/antibody complexes in patients with mixed essential cryoglobulinemia type II.
Madi N; Steiger G; Estreicher J; Schifferli JA
J Immunol; 1991 Jul; 147(2):495-502. PubMed ID: 2071892
[TBL] [Abstract][Full Text] [Related]
11. Immune adherence and clearance of hepatitis B surface Ag/Ab complexes is abnormal in patients with systemic lupus erythematosus (SLE).
Madi N; Steiger G; Estreicher J; Schifferli JA
Clin Exp Immunol; 1991 Sep; 85(3):373-8. PubMed ID: 1893616
[TBL] [Abstract][Full Text] [Related]
12. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
13. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
Pascual M; Schifferli JA
Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
[TBL] [Abstract][Full Text] [Related]
14. Direct evidence for the clustered nature of complement receptors type 1 on the erythrocyte membrane.
Paccaud JP; Carpentier JL; Schifferli JA
J Immunol; 1988 Dec; 141(11):3889-94. PubMed ID: 2972779
[TBL] [Abstract][Full Text] [Related]
15. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
16. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
Madi N; Paccaud JP; Steiger G; Schifferli JA
Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
[TBL] [Abstract][Full Text] [Related]
17. Proteolytic cleavage of CR1 on human erythrocytes in vivo: evidence for enhanced cleavage in AIDS.
Pascual M; Danielsson C; Steiger G; Schifferli JA
Eur J Immunol; 1994 Mar; 24(3):702-8. PubMed ID: 7510241
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte complement receptor type 1 and interactions between immune complexes, neutrophils, and endothelium.
Beynon HL; Davies KA; Haskard DO; Walport MJ
J Immunol; 1994 Oct; 153(7):3160-7. PubMed ID: 8089493
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.
Edberg JC; Wright E; Taylor RP
J Immunol; 1987 Dec; 139(11):3739-47. PubMed ID: 2960742
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analyses of C3b capture and immune adherence of IgM antibody/dsDNA immune complexes.
Taylor RP; Wright EL; Pocanic F
J Immunol; 1989 Dec; 143(11):3626-31. PubMed ID: 2584711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]